Vivos Therapeutics, Inc. (VVOS)
NASDAQ
Vivos Therapeutics, Inc. Shareholder Equity 2019–2025
Vivos Therapeutics, Inc. annual shareholder equity history from 2019 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Vivos Therapeutics, Inc. shareholder equity as of December 31, 2025: -1.5M, a 118.73% decrease year-over-year.
- Vivos Therapeutics, Inc. shareholder equity for 2025 were -1.5M, a 118.73% decrease from 2024.
- Vivos Therapeutics, Inc. shareholder equity for 2024 were 8.0M, a 1835.28% increase from 2023.
- Vivos Therapeutics, Inc. shareholder equity for 2023 were 411,000, a 91.44% decrease from 2022.
- Vivos Therapeutics, Inc. shareholder equity for 2022 were 4.8M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Vivos Therapeutics, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $-1 |
| 2024 | $8 |
| 2023 | $0 |
| 2022 | $5 |
| 2021 | $26 |
| 2020 | $17 |
| 2019 | $-3 |
Vivos Therapeutics, Inc. Shareholder Equity — FAQ
Vivos Therapeutics, Inc. (VVOS) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VVOS's shareholder equity history?
The chart and table above show Vivos Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.